Friday, October 30, 2026
ExploreSearch
Finance Via News
Via News Knowledge File

Tesla Inc.

organization80% conf.·synced Oct 29, 2026

Electric vehicle and clean energy company

60
sourced metrics
1601
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
374.58USD
Oct 22, 2026reference only
Price 52 Week Low
298.32USD
Oct 22, 2026reference only
Price 52 Week High
489.88USD
Oct 22, 2026reference only
Market Cap
1479421462845USD
Oct 22, 2026reference only
Stock Return Ytd
-14.5%
Oct 22, 2026reference only
Shares Outstanding
3949547394.0shares
Jul 16, 2026reference only
Cost Of Revenue
23485000000.0USD
Jun 30, 2026reference only
Total Assets
148524000000.0USD
Jun 30, 2026reference only
Total Liabilities
61005000000.0USD
Jun 30, 2026reference only
Revenue
28236000000.0USD
Jun 30, 2026reference only
Stockholders Equity
86858000000.0USD
Jun 30, 2026reference only
Net Income
1114000000.0USD
Jun 30, 2026reference only
Gross Profit
4751000000.0USD
Jun 30, 2026reference only
Eps
0.32USD_per_share
Jun 30, 2026reference only
Cash
15219000000.0USD
Jun 30, 2026reference only
Operating Income
398000000.0USD
Jun 30, 2026reference only
Rd Expense
2371000000.0USD
Jun 30, 2026reference only
Operating Cash Flow
3937000000.0USD
Mar 31, 2026reference only

Stated objectives

Build gigantic chip fab for AI and potentially work with Intel

source
stated

Unveil new Tesla Roadster on April 1 and begin production one year later

source
by 2027-04-01 00:00:00stated

Deliver on promises for robotaxi and Optimus humanoid robot

source
stated

Deepen collaboration on AI technology for vehicles, robotics and autonomous systems through investment in xAI

source
stated

Strategic shift from EVs to robots and autonomy-based future

source
stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas

source
target: 7 metro areas stated

Production of Optimus humanoid robots

source
target: production launch stated

Begin production of Optimus humanoid robots by end of year

source
by 2026-12-31 00:00:00stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas in first half of 2026

source
target: 7 cities by 2026-06-30 00:00:00stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas

source
target: 7 new cities stated

Relationship graph · 1601 connections

Competes with
314
Developed by
301
Employs
208
Covered by
162
Invested in
82
Supplies to
79
founded
64
Owns
56

Where sources disagree

We surface conflicts between sources rather than hiding them.

value conflictunresolved

Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).

source B
value conflictunresolved

Both facts report EPS (earnings per share) for Tesla Inc. for the identical fiscal period (Q1 2026) and observation date (2026-03-31), but state conflicting values: 0.13 USD/share vs. 0.41 USD. Same entity, same metric, same time period, different reported values.

source B

Via News coverage

BYD Plans 20,000 Flash Charging Stations by 2026, Outpacing Tesla at Three Times the Speed
June 19, 2026
SOXX Returned 79% YTD as AI Chip Race Splits Into Efficiency vs. Independence
June 17, 2026
10-Year Treasury Yield Climbs to 4.43% as Tesla Drops 3% on $25B Capex Announcement
April 26, 2026
Semiconductor Firms Restructure Supply Chains Ahead of 2027 Chinese Rare Earth Ban
April 24, 2026
U.S. 2027 Rare Earth Ban Forces Defense Semiconductor Supply Chain Overhaul
April 22, 2026
OMNIQ Reports 98.6% Loss Reduction and 60.5% Gross Profit Surge as Enterprise AI Deployment Accelerates
April 21, 2026
Tesla Valuation Driven by AI Narrative Over EV Fundamentals, Analysts Say
April 21, 2026
Tech Giants Pivot to Vertical Integration as AI Chip Demand Reshapes Semiconductor Partnerships
April 20, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,503 source documents archived
Query this data → isubstrate.com